Search | IOVS | ARVO Journals

Showing 1 – 20 of 42

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Imaging in the Eye Conference Abstract August 2021

Multimodal imaging in eyes with presumed dysfunction of the retinooptic barrier

Heinrich Gerding

Invest. Ophthalmol. Vis. Sci.. 2021; 62(11):77. doi:

ARVO Imaging in the Eye Conference Abstract July 2020

SD-OCT findings after 10 years of AMD anti-VEGF treatment

Heinrich Gerding

Invest. Ophthalmol. Vis. Sci.. 2020; 61(9):PB0038. doi:

ARVO Annual Meeting Abstract July 2019

TEN-YEAR RESULTS OF WET AGE-RELATED MACULAR DEGENERATION ANTI-VEGF TREATMENT

Heinrich Gerding; Lars Hefner; Melanie Timmermann; Katarina Hurtikova; Gabor Somfai

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):119. doi:

Articles July 2018

Safety and Feasibility of a Novel Sparse Optical Coherence Tomography Device for Patient-Delivered Retina Home Monitoring

PDF

Peter Maloca; Pascal W. Hasler; Daniel Barthelmes; Patrik Arnold; Mooser Matthias; Hendrik P. N. Scholl; Heinrich Gerding; Justus Garweg; Tjebo Heeren; Konstantinos Balaskas; J. Emanuel Ramos de Carvalho; Catherine Egan; Adnan Tufail; Sandrine A. Zweifel
TAGS: optical coherence tomography, retina, safety, eye
Trans. Vis. Sci. Tech.. 2018; 7(4):8. doi: https://doi.org/10.1167/tvst.7.4.8

ARVO Annual Meeting Abstract June 2017

Outer retinal changes in patients with diabetes and no or mild non-proliferative diabetic retinopathy

Gabor Mark Somfai; Jing Tian; Wen-Hsiang Lee; Richard K Lee; Ajay E. Kuriyan; Ninel Gregori; William J Feuer; Wei Shi; Sandra Pineda; Heinrich Gerding; William Smiddy; Delia Cabrera DeBuc

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):101. doi:

ARVO Annual Meeting Abstract September 2016

Two cases of unexpected radiation retinopathy: one after 20 Gy orbital and one after 30 Gy whole-brain radiation

Katarina Hurtikova; Scott Tschuppert; Heinrich Gerding

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4172. doi:

ARVO Annual Meeting Abstract September 2016

The Assessment of Henle Fiber Layer-Related Imaging Patterns on Directional OCT Scans of the Macula

Gabor Mark Somfai; Jing Tian; Delia DeBuc; Heinrich Gerding

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):439. doi:

ARVO Annual Meeting Abstract September 2016

Acute, postoperative, transient retinal detachment (APTRD) after intraocular surgery: a new clinical entity

Heinrich Gerding

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1043. doi:

ARVO Annual Meeting Abstract June 2015

7-YEARS RESULTS OF PRN ANTI-VEGF TREATMENT IN AGE-REALATED MACULAR DEGENERATION

Heinrich Gerding

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5380. doi:

ARVO Annual Meeting Abstract April 2014

Efficacy and safety of ranibizumab 0.5 mg in patients with visual impairment due to macular edema secondary to central retinal vein occlusion: Design and baseline characteristics of the CRYSTAL study

Francesco Boscia; Heinrich Gerding; Ian A Pearce; Siegfried Priglinger; Ramin Tadayoni; Jackie Han; George Lambrou; William John Stubbings; Jordi M Mones

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):606. doi:

ARVO Annual Meeting Abstract April 2014

Ranibizumab ±adjunctive laser vs laser in patients with visual impairment due to macular edema secondary to branch retinal vein occlusion (BRVO): Design and baseline characteristics of the BRIGHTER study

Heinrich Gerding; Francesco Boscia; Jordi M Mones; Siegfried Priglinger; Ramin Tadayoni; Jackie Han; George Lambrou; William John Stubbings; Ian A Pearce

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):607. doi:

ARVO Annual Meeting Abstract March 2012

Regional Defects Of Rpe-Pigmentation And Abnormal Vecp Amplitude Shift In A Patient With Prader Willi-Syndrome Indicate An Atypical Form Of Incomplete Albinism

Melanie Timmermann; Heinrich Gerding

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):980. doi:

ARVO Annual Meeting Abstract March 2012

Results Of Flexible Ranibizumab Treatment After Four Years In Age-related Macular Degeneration

Heinrich Gerding; Lars Hefner; Melanie Timmermann

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5170. doi:

ARVO Annual Meeting Abstract March 2012

Hole Position In Rhegmatogenous Retinal Detachment: A Analysis Of Mustard, A Retrospective Interventional Case Series Of 4325 Participants In Relation To The Lincoff-rules"

Ulrich Thelen; Heinrich Gerding

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5795. doi:

ARVO Annual Meeting Abstract April 2011

Staining Of The Internal Limiting Membrane With A Novel Heavy Brilliant Blue G-solution

Heinrich Gerding; Melanie Timmermann

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):6109. doi:

ARVO Annual Meeting Abstract April 2010

Staining of the ILM With Brilliant Blue G (Brilliant Peel®): Safety and Efficacy

H. Gerding; M. Timmermann; U. Thelen

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):2552. doi:

ARVO Annual Meeting Abstract April 2009

Clinical Results of pp-Vitrectomy With Densiron 68® Heavy Internal Tamponade Used for Primary Surgery in Eyes With Complicated Rhegmatogenous Retinal Detachment and Clinically Significant PVR

H. Gerding; V. Loukopoulos; J. Riese; L. Hefner; C. Meier; Z. Liampa; M. Timmermann

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):3172. doi:

ARVO Annual Meeting Abstract April 2009

How Precise Is the Dose When We Are Injecting Ranibizumab?

M. Timmermann; H. Gerding

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):1895. doi:

ARVO Annual Meeting Abstract May 2008

Combination With Low-Dose Triamcinolone Prolongs the Effect of Bevacizumab in Patients With Acute Exsudative Age Related Macular Degeneration

H. Gerding; J. Riese; V. Loukopoulos; C. Meier; U. Thelen; M. Timmermann

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):569. doi:

ARVO Annual Meeting Abstract May 2008

Focal Laser Photocoagulation Facilitated by Previous Intravitreal Triamcinolone in Eyes With Clinically Significant Diabetic Macular Edema: 6 Months Results

M. Timmermann; J. Riese; V. Loukopoulos; C. Meier; H. Gerding

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):3477. doi:

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Multimodal imaging in eyes with presumed dysfunction of the retinooptic barrier

SD-OCT findings after 10 years of AMD anti-VEGF treatment

TEN-YEAR RESULTS OF WET AGE-RELATED MACULAR DEGENERATION ANTI-VEGF TREATMENT

Safety and Feasibility of a Novel Sparse Optical Coherence Tomography Device for Patient-Delivered Retina Home Monitoring

Outer retinal changes in patients with diabetes and no or mild non-proliferative diabetic retinopathy

Two cases of unexpected radiation retinopathy: one after 20 Gy orbital and one after 30 Gy whole-brain radiation

The Assessment of Henle Fiber Layer-Related Imaging Patterns on Directional OCT Scans of the Macula

Acute, postoperative, transient retinal detachment (APTRD) after intraocular surgery: a new clinical entity

7-YEARS RESULTS OF PRN ANTI-VEGF TREATMENT IN AGE-REALATED MACULAR DEGENERATION

Efficacy and safety of ranibizumab 0.5 mg in patients with visual impairment due to macular edema secondary to central retinal vein occlusion: Design and baseline characteristics of the CRYSTAL study

Ranibizumab ±adjunctive laser vs laser in patients with visual impairment due to macular edema secondary to branch retinal vein occlusion (BRVO): Design and baseline characteristics of the BRIGHTER study

Regional Defects Of Rpe-Pigmentation And Abnormal Vecp Amplitude Shift In A Patient With Prader Willi-Syndrome Indicate An Atypical Form Of Incomplete Albinism

Results Of Flexible Ranibizumab Treatment After Four Years In Age-related Macular Degeneration

Hole Position In Rhegmatogenous Retinal Detachment: A Analysis Of Mustard, A Retrospective Interventional Case Series Of 4325 Participants In Relation To The Lincoff-rules"

Staining Of The Internal Limiting Membrane With A Novel Heavy Brilliant Blue G-solution

Staining of the ILM With Brilliant Blue G (Brilliant Peel®): Safety and Efficacy

Clinical Results of pp-Vitrectomy With Densiron 68® Heavy Internal Tamponade Used for Primary Surgery in Eyes With Complicated Rhegmatogenous Retinal Detachment and Clinically Significant PVR

How Precise Is the Dose When We Are Injecting Ranibizumab?

Combination With Low-Dose Triamcinolone Prolongs the Effect of Bevacizumab in Patients With Acute Exsudative Age Related Macular Degeneration

Focal Laser Photocoagulation Facilitated by Previous Intravitreal Triamcinolone in Eyes With Clinically Significant Diabetic Macular Edema: 6 Months Results

To View More...

You must be signed into an individual account to use this feature.